CELL-PENETRATING PEPTIDE FUSION PROTEINS - Fusion Protein Technologies for Biopharmaceuticals: Applications and Challenges - page 394

cerebral ischemia in mice. J. cereb. blood flow metab. 29,
1187-1196.
46. Dilber MS, Phelan A, Aints A, Mohamed A, Elliott G, Smith
C, et al. (1999) Intercellular delivery of thymidine kinase
prodrug activating enzyme by the herpes simplex virus
protein, VP22. Gene Ther. 6, 12-21.
47. Blackwell N, Sembi P, Newson J, Lawrence T, Gilroy D,
Kabouridis P. (2004) Reduced infiltration and increased
apoptosis of leukocytes at sites of inflammation by systemic
administration of a membrane-permeable IkappaBalpha
repressor. Arthritis Rheum. 50, 2675-2684.
48. Patel EN, Wang J, Kim K, Borok Z, Crandall ED, Shen W.
(2009) Conjugation with cationic cell-penetrating peptide
increases pulmonary absorption of insulin. Mol. Pharm. 6,
492-503.
49. Racanicchi S, Maccherani C, Liberatore C, Billi M, Gelmetti
V, Panigada M, et al. (2005) Targeting fusion pro-
tein/corepressor contact restores differentiation response in
leukemia cells. EMBO J. 24, 1232-1242.
50. Bleifuss E, Kammertoens T, Hutloff A, Quarcoo D, Dorner
M, Straub P, et al. (2006) The translocation motif of hepatitis
B virus improves protein vaccination. Cell. Mol. Life Sci. 63,
627-635.
51. Ezhevsky S, Nagahara H, Vocero-Akbani AM, Gius D, Wei
M, Dowdy S. (1997) Hypo-phosphorylation of the retinoblas-
toma protein (pRb) by cyclin D:Cdk4/6 complexes results in
active pRb. Proc. Natl. Acad. Sci. USA 94, 10699-10704.
52. Nagahara H, Vocero-Akbani AM, Snyder E, Ho A, LathamD,
Lissy N, et al. (1998) Transduction of full-length TAT fusion
proteins into mammalian cells: TAT-p27Kip1 induces cell
migration. Nat. Med. 4, 1449-1452.
53. Phelan A, Elliott G, O'Hare P. (1998) Intercellular delivery of
functional p53 by the herpesvirus protein VP22. Nat. Biotech.
16, 440-443.
54. Wills K, Atencio I, Avanzini J, Neuteboom S, Phelan A,
Philopena J, et al. (2001) Intratumoral spread and increased
efficacy of a p53-VP22 fusion protein expressed by a recom-
binant adenovirus. J. Virol. 75, 8733-8741.
55. Zender L, Kock R, Eckhard M, Frericks B, Gosling T,
Gebhardt T, et al. (2002) Gene therapy by intrahepatic and
intratumoral trafficking of p53-VP22 induces regression of
liver tumors. Gastroenterology 123, 608-618.
56. Kubo E, Singh DP, Fatma N, Akagi Y. (2009) TAT-mediated
peroxiredoxin 5 and 6 protein transduction protects against
high-glucose-induced cytotoxicity in retinal pericytes. Life
Sci. 84, 857-864.
57. Avignolo C, Bagnasco L, Biasotti B, Melchiori A, Tomati V,
Bauer I, et al. (2008) Internalization via Antennapedia protein
transduction domain of an scFv antibody toward c-Myc
protein. FASEB J. 22, 1237-1245.
58. Shin I, Edl J, Biswas S, Lin P, Mernaugh R, Arteaga C. (2005)
Proapoptotic activity of cell-permeable anti-Akt single-chain
antibodies. Cancer Res. 65, 2815-2824.
59. Becker-Hapak M, Mcallister S, Dowdy S. (2001) TAT-medi-
ated protein transduction into mammalian cells. Methods 24,
247-256.

60. Abu-Amer Y, Dowdy SF, Ross F, Clohisy J, Teitelbaum S.
(2001) TAT fusion proteins containing tyrosine 42-deleted
IkappaBalpha arrest osteoclastogenesis. J. Biol. Chem. 276,
30499-30503.
61. Dietz GP, Kilic E, Bahr M. (2002) Inhibition of neuronal
apoptosis in vitro and in vivo using TAT-mediated protein
transduction. Mol. Cell. Neurosci. 21, 29-37.
62. Doeppner T, Dietz G, El Aanbouri M, Gerber J, Witte O, Bahr
M, et al. (2009) TAT-Bcl-x(L) improves survival of neuronal
precursor cells in the lesioned striatum after focal cerebral
ischemia. Neurobiol. Dis. 34, 87-94.
63. Doeppner T, Dietz G, Weise J, Bahr M. (2010) Protection of
hippocampal neurogenesis by TAT-Bcl-x(L) after cerebral
ischemia in mice. Exp. Neurol. 223, 548-556.
64. Doeppner T, El Aanbouri M, Dietz G, Weise J, Schwarting S,
Bahr M. (2010) Transplantation of TAT-Bcl-xL-transduced
neural precursor cells: long-term neuroprotection after stroke.
Neurobiol. Dis. 40, 265-276.
65. Guelen L, Paterson H, Gaken J, Meyers M, Farzaneh F,
Tavassoli M. (2004) TAT-apoptin is efficiently delivered and
induces apoptosis in cancer cells. Oncogene 23, 1153-1165.
66. Gustafsson A, Sayen M, Williams S, Crow M, Gottlieb R.
(2002) TAT protein transduction into isolated perfused hearts:
TAT-apoptosis repressor with caspase recruitment domain is
cardioprotective. Circulation 106, 735-739.
67. Hudecz F, Banoczi Z, Csik G. (2005) Medium-sized peptides
as built in carriers for biologically active compounds. Med.
Res. Rev. 25, 679-736.
68. Kilic E, Dietz G, Hermann D, Bahr M. (2002) Intravenous
TAT-Bcl-Xl is protective after middle cerebral artery occlu-
sion in mice. Ann. Neurol. 52, 617-622.
69. Kilic U, Kilic E, Dietz G, Bahr M. (2003) Intravenous TAT-
GDNF is protective after focal cerebral ischemia in mice.
Stroke 34, 1304-1310.
70. Ribeiro M, Klein D, Pileggi A, Molano RD, Fraker C, Ricordi
C, et al. (2003) Heme oxygenase-1 fused to a TAT peptide
transduces and protects pancreatic beta-cells. Biochem.
Biophys. Res. Commun. 305, 876-881.
71. Schwarze S, Dowdy S. (2000) In vivo protein transduction:
intracellular delivery of biologically active proteins, com-
pounds and DNA. TrendsPharmacol. Sci. 21, 45-48.
72. Souktani R, Pons S, Guegan C, Bouhidel O, Bruneval P,
Zini R, et al. (2009) Cardioprotection against myocardial
infarction with PTD-BIR3/RING, a XIAP mimicking protein.
J. Mol. Cell. Cardiol. 46, 713-718.
73. Tinega A, Pelle R, Kang'A, S. Gicheru M, Taracha E, Nene V,
et al. (2009) Fusion of a cell penetrating peptide from HIV-1
TAT to the Theileria parva antigen Tp2 enhances the stimu-
lation of bovine CD8 þ T cell responses. Vet. Immunol.
Immunopathol. 130, 107-113.
74. Viehl C, Tanaka Y, Chen T, Frey D, Tran A, Fleming T, et al.
(2005) Tat mammaglobin fusion protein transduced dendritic
cells stimulate mammaglobin-specific CD4 and CD8 T cells.
Breast Cancer Res. Treat. 91, 271-278.
75. Vitali R, Cesi V, Tanno B, Ferrari-Amorotti G, Dominici C,
Calabretta B, et al. (2008) Activation of p53-dependent